Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You may want to consider holding for 3-5 years so that you can buy a nice house to go along with that nice truck. GL.
Ticker on Stuttgart and Berlin exchanges is NBYB.
Would you mind sharing your Twitter URL here? I want to make sure I’m not missing your much appreciated efforts.
I think there’s a possibility that Linda Powers will settle, but for an astronomical amount that’s offered.
kab, I’m catching up on posts. Do we know for sure that cease and desist orders are now in place for all the defendants? Thx
Crash, do you know if a judge could order all the defendants to cease and desist all trading activities re: NWBO until a judgement is made. Any idea? Anyone? TIA
Now that could legitimately be called a “pump and dump” scheme. However, the expert speculations of longs on this board are not, regardless of being accused of such tactics.
I’m not a journalist, but I think it’s too early for major US/UK news media to publish our story. However, if BP partners or if an RA approves, then they are more likely to pick it up. Most of us waited through the FUD like data lock will never happen, top line data will never happen, the journal article will never happen, and the ASM will never happen, and on and on, And look where we find ourselves today. So, unless one has to come up with bail money in a hurry, the short-term PPS volatility is insignificant and something we just may have to live with for a few more months. Pull back and imagine where we’ll be in a year.
If history is any indication, that won’t be the case. We were at 14 cents not too long ago, and since then have hit ~$2 twice. Now the word is getting out, exponentially, and even without institutional investors, smart rich people will start to buy more and more in the coming days, weeks, and months. Someone posted we stay red until ASM without news. I’ve been watching this stock for ten years, and I think we will easily be over $1 by Christmas with no news.
Count me in for a big YES vote, too. Receipt of news or a detailed plan beforehand would be nice, but I am not worried about whether or not the company will eventually get regulatory approval. Anyone know when the proxies should arrive in our inboxes?
TDAmeritrade assured me twice in the past 1-3 years that the NWBO shares in my margin account wouldn’t be loaned out after I expressed my concern. But because the written contract/agreement states otherwise, I went ahead and removed the margin last Friday to be safe. It can always be added back later.
Yes, I think that was the same physician that called himself a moron for chiming in before he read the JAMA Oncology article.
Temperature swings for sure, but not necessary freezing as there were a ton of potholes on the highways in Saudi Arabia, which got very chilly during winter nights. I also heard the quality/grade of the asphalt is a factor, as well as the heavy trucks that use the roads.
Viking, as I’m sure you and most others are aware, forming a SPAC or some other new corporate structure, even alongside a partnership/milestone-based buyout, is right up LP’s alley. I would expect this sort of strategy before a reverse split if it’s needed.
Patty, that’s good to hear. This board gets emotional sometimes, doesn’t it? I definitely would have to plead guilty. :) Best.
Patty, so you are seriously siding with your BP contact’s verbal statement stacked up against the mountain of expert analysis on this forum over the past several months. I am 100% convinced that your new position is not a valid argument that would result in the FDA not approving. Maybe you aren’t following the board as close as I am, but your slant has already been debunked with sound in-depth analysis of the data. GL
Crash, I also emailed them about same.
From reading previous posts, I gather some of us will be selling a small portion of our holdings somewhere between $3-10. I think Maverick’s comment the other day on how to go about doing this is worth repeating. I’m paraphrasing but he suggested not to sell large blocks of shares at once and to enter a limit above the bid price when entering orders. This strategy may require some discipline and patience over a day or two, but our core positions will be the better for it.
I got this one. I’ll give you a hint; it begins with an “m”. Just kidding M. :)
Avoid oatmeal cookies from The Dollar Store. They’re dirt cheap because that’s one of the ingredients.
Quebec, papa, over…. ;)
…with a complicated investment.
Wrong again Dr Low. “Today, two different organizations must approve the names of generic drugs— the United States Adopted Names (USAN) Council and the World Health Organization (WHO) INN Programme —so that regardless of where someone is located, patients and health care professionals will be able to safely communicate about medications.” https://www.pfizer.com/news/articles/ever_wonder_how_drugs_are_named_read_on
Fair enough. Any GBM patients lurking here would probably have missed the humor too.
Jerry, on Nov. 9, you stated, “7 workstreams. Each no doubt includes one or more multi-month processes. End of the year 2024 seems entirely possible for manufacturing. BLA or other submission to regulators seems less planned out. Might take longer.” Now you are claiming you never suggested delayed approval but that DCVac-L likely won’t be approved. Well, that’s even more absurd. Thanks for the clarification.
It would be pretty sneaky of them not to PR MAA submission, but I’m not counting on it. Talk about your short squeezes with a PR on approval out of the blue. We can only dream, for now.
Ex, as you well know, the delayed approval narrative that Jerry started after the 10Q release was completely debunked yesterday.
Nothing to worry about. In general, the data is impressive, but a lot of discussion is taking place regarding the details.
Thanks Dr B, a little levity never hurts. :)
I think the consensus was that the SNO abstract would be released on Friday at 7 a.m. EST.
The 10Q states, “The Ancillary Services Agreement had an original term of eight months, which ended in July 2020. The Company extended the term by 12 months to July 2021 and another 12 months to July 2022, with no other changes, and recently extended it for another 12 months to July 2023.” It seems to me that these agreements have consistently been renewed for 12-month periods as a formality with the previous one expiring July 2022. I don’t believe it’s a reasonable inference to conclude that the SOWs won’t be completed until the next expiration date of July 2023.
Jerry, as my English friend used to say, "Are you winding me up?", lol. It's not like the clock on the workstreams' multi-month processes started this evening with the release of the 10Q. Did this thought of yours concerning the seven workstreams completion date being the end of 2024 just occur to you this evening? A thought just occurred to me this evening that all the workstreams might be completed by the end of this month, and the MAA/BLA by the end of this year. Thoughts are funny like that.
Yes, he’s that diabolical, but better Santa than NWBO if Ex’s $.61 YE pps prediction is to be avoided. I don’t know about YE, but I suspect we will be at $10-15 before 1Q ends next year.
Ex, is AF planning a holiday hit piece?
Happy, “If you want to hear God speak, read your Bible. If you want to hear God speak audibly, read your Bible out loud.” — Justin Peters
Dr. Low, don’t forget Gary’s previous post noting that the DCVax-L journal article may be in SNO’s peer-reviewed journal called Neuro-Oncology Advances published by Oxford University Press.
The reason for my comment concerning Merck having influence with the FDA is from articles like this one from Science Magazine in 2018. Scroll down to the “Pick a Drug” Section and select Seroquel XR and Zyprexa Relprevv from the drop-down menu. https://www.science.org/content/article/hidden-conflicts-pharma-payments-fda-advisers-after-drug-approvals-spark-ethical
Yep, it’s clear that NWBO’s success is in Merck’s financial interest, and the latter holds sway with the FDA. Now we’re getting somewhere.
Well, I do agree the pps should be around $5 today, but I don’t agree whose fault it is that it isn’t. The only legitimate “complaint” as I see it would be a legal one against people like Ken Griffith at Citadel and Adam F. at STAT News. Linda Powers made a strategic mistake several years ago in underestimating the strength of those intent putting NWBio out of business out of greed and disregard for cancer patients, but her excellent business skills and intellect overcame those obstacles where many others would have failed. I have complete confidence in her ability to bring the DCVax platform to market in the very near future, to reward long investors, and to prolong and save the lives of cancer patients all over the world. May God bless NWBO, the physicians involved in the trial, Advent, and all the RAs in the coming weeks and months. It may take longer than we expect, but the pps will be a fair one eventually.